Insider · CIK 0001956241

Xynos Konstantinos

Reports to the SEC for 1 company · WOBURN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001956241

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-10	REPLReplimune Group, Inc.S Sale	Chief Medical Officer	SSale	−11.4K sh	$12.97	−$148K	224,215
2026-05-18	REPLReplimune Group, Inc.S Sale	Chief Medical Officer	SSale	−14K sh	$5.08	−$71.2K	235,662
2026-04-01	REPLReplimune Group, Inc.A Award	Chief Medical Officer	AAward	+50K sh	—	—	249,685
2026-04-01	REPLReplimune Group, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+75K sh	—	—	75,000
2025-12-19	REPLReplimune Group, Inc.A Award	Chief Medical Officer	AAward	+60K sh	—	—	199,685
2025-11-17	REPLReplimune Group, Inc.S Sale	Chief Medical Officer	SSale	−7,248 sh	$9.10	−$66K	139,685
2025-05-20	REPLReplimune Group, Inc.S Sale	Chief Medical Officer	SSale	−7,952 sh	$8.06	−$64.1K	146,933
2025-04-01	REPLReplimune Group, Inc.A Award	Chief Medical Officer	AAward	+45K sh	—	—	154,885
2025-04-01	REPLReplimune Group, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+67.5K sh	—	—	67,500
2024-11-18	REPLReplimune Group, Inc.S Sale	Chief Medical Officer	SSale	−7,246 sh	$10.78	−$78.1K	109,885
2024-06-07	REPLReplimune Group, Inc.S Sale	Chief Medical Officer	SSale	−15.9K sh	$7.50	−$119K	117,131
2024-05-16	REPLReplimune Group, Inc.S Sale	Chief Medical Officer	SSale	−6,367 sh	$6.47	−$41.2K	133,012
2024-04-01	REPLReplimune Group, Inc.A Award	Chief Medical Officer	AAward	+26.7K sh	—	—	139,379
2024-04-01	REPLReplimune Group, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+80K sh	—	—	80,000
2023-11-16	REPLReplimune Group, Inc.S Sale	Chief Medical Officer	SSale	−7,313 sh	$10.92	−$79.9K	112,714
2023-05-16	REPLReplimune Group, Inc.S Sale	Chief Medical Officer	SSale	−771 sh	$18.05	−$13.9K	120,027
2023-04-01	REPLReplimune Group, Inc.A Award	Chief Medical Officer	AAward	+50K sh	—	—	120,798
2023-04-01	REPLReplimune Group, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+75K sh	—	—	75,000
2022-12-01	REPLReplimune Group, Inc.A Award	Chief Medical Officer	AAward	+17.5K sh	—	—	70,798
2022-12-01	REPLReplimune Group, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+26.3K sh	—	—	26,250

Recent filings

Accepted (ET)
Aug 124
Xynos Konstantinos0001104659-26-095006
SEC(opens sec.gov)
May 204
Xynos Konstantinos0001104659-26-064526
SEC(opens sec.gov)
Apr 74
Xynos Konstantinos0001104659-26-040575
SEC(opens sec.gov)
Dec 194
Xynos Konstantinos0001104659-25-123286
SEC(opens sec.gov)
Nov 194
Xynos Konstantinos0001104659-25-114122
SEC(opens sec.gov)
May 224
Xynos Konstantinos0001104659-25-052145
SEC(opens sec.gov)
Apr 34
Xynos Konstantinos0001104659-25-031832
SEC(opens sec.gov)
Nov 204
Xynos Konstantinos0001104659-24-121188
SEC(opens sec.gov)
Jun 104
Xynos Konstantinos0001104659-24-070108
SEC(opens sec.gov)
May 204
Xynos Konstantinos0001104659-24-063558
SEC(opens sec.gov)
Apr 34
Xynos Konstantinos0001104659-24-043256
SEC(opens sec.gov)
Nov 174
Xynos Konstantinos0001104659-23-119646
SEC(opens sec.gov)
May 184
Xynos Konstantinos0001104659-23-062373
SEC(opens sec.gov)
Apr 44
Xynos Konstantinos0001104659-23-041726
SEC(opens sec.gov)
Dec 54
Xynos Konstantinos0001104659-22-124656
SEC(opens sec.gov)

Companies

Replimune Group, Inc.Chief Medical OfficerREPL

Address

C/O REPLIMUNE GROUP, INC. 500 UNICORN PARK DRIVE, SUITE 303

WOBURN, MA, 01801